BRIEF-Merck KGaA Receives Patent For CRISPR Technology In ChinaReutersBRIEF-Merck KGaA Receives Patent For CRISPR Technology In China. Reuters Staff. 1 Min Read. April 23 (Reuters) – Merck KGaA: * MERCK RECEIVES PATENT FOR CRISPR TECHNOLOGY IN CHINA So… Continue reading
Mirage NewsMerck receives patent for CRISPR tech in ChinaMarketWatchMerck KGaA (MRK.XE) said Monday that it has received a patent for its CRISPR genome-editing technology in China. The CRISPR technology allows for precise chromosome modification in liv… Continue reading
Drug Target Review |
DNA editing outside the cell with CRISPR could improve cancer diagnosis
BioNews ‘Cell-free’ CRISPR has been developed by scientists at the Christine Care Health System’s Gene Editing Institute in Delaware, US, allowing them to extract cellular DNA and make multiple, significant edits to the genetic code. Researchers used the … CRISPR used to edit DNA outside of the cell – DTRDrug Target Review Scientists use CRISPR tool to make multiple edits to DNA samples …News-Medical.net |